CNTX 10-Q: SEC filing

Context Therapeutics Inc.

Filed with the SEC on Nov 10, 2026 · accession 0001628280-26-072730

CNTX filed a 10-Q (quarterly report) with the SEC on Nov 10, 2026. The quarterly report: unaudited results for the quarter plus management’s comments. The stock moved -6.6% by the first close after the filing.

Summary of the filing

Context Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates for the third quarter.

For details, click here →How to read a 10-Q →

Key details

FilerContext Therapeutics Inc.

Collaboration partnerIntegral Molecular, Inc.

Collaboration partnerBioAtla, Inc.

How CNTX stock reacted

Close before

$0.20

Nov 9, 2026

First close after

-6.64%

$0.19

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for CNTX, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for CNTX?

Click here

Frequently asked questions

What did CNTX file with the SEC on Nov 10, 2026?

CNTX filed a 10-Q (SEC filing). Context Therapeutics Inc. filed its quarterly report on Form 10-Q for the period ended September 30, 2026, reporting financial results and business updates for the third quarter.

How do I read a 10-Q?

The quarterly report: unaudited results for the quarter plus management’s comments. Compare revenue, margins and cash flow with the same quarter last year. Check MD&A for guidance changes and what drove the quarter.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 10-Q (quarterly report): The quarterly report: unaudited results for the quarter plus management’s comments.

How did CNTX stock react to this filing?

CNTX closed at $0.20 before the filing and $0.19 on Nov 10, 2026 (-6.64%).

Other CNTX SEC filings

Get alerts when CNTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days

CNTX overview CNTX analysis CNTX news Latest SEC filings